Comparison of Perineural Catheter Depth for the Continuous Popliteal Nerve Block Using Ultrasound Guidance and Dermabond

This study is currently recruiting participants.
Verified December 2012 by Vanderbilt University
Sponsor:
Information provided by (Responsible Party):
Clifford Bowens, Vanderbilt University
ClinicalTrials.gov Identifier:
NCT01591603
First received: April 23, 2012
Last updated: December 20, 2012
Last verified: December 2012

April 23, 2012
December 20, 2012
May 2012
May 2013   (final data collection date for primary outcome measure)
Change in Peripheral block score (PBS). [ Time Frame: 10, 20, and 30 minutes after intervention ] [ Designated as safety issue: No ]
The extent of popliteal nerve blockade will be captured with four sensory groups (sural, superficial peroneal, tibial, and deep peroneal) and three motor groups (superficial peroneal, tibial, and deep peroneal). For each group, a score of 0, 1, or 2 will be assigned based on complete, partial, or no blockade, respectively. The peripheral block score (PBS) outcome variable will be based on the sum of these values and will range from 0 to 14.
Same as current
Complete list of historical versions of study NCT01591603 on ClinicalTrials.gov Archive Site
  • Pain score [ Time Frame: Arrival to PACU (Immediately after surgery, approximately 3-5 hours after intervention) ] [ Designated as safety issue: No ]
    The investigators will examine the difference in the pain scores (0-10 numeric rating scale) between the two groups.
  • Analgesia failure rate [ Time Frame: Arrival to PACU (Immediately after surgery, approximately 3-5 hours after intervention) ] [ Designated as safety issue: No ]
    The investigators will examine the difference in analgesia failure rates in the PACU. Analgesia failure is defined as the failure of a rescue bolus (to treat patient pain).
  • Catheter dislodgement rates [ Time Frame: Arrival to PACU (Immediately after surgery, approximately 3-5 hours after intervention) ] [ Designated as safety issue: No ]
    The investigators will examine the difference in the catheter dislodgement rates.
  • Difference in total opioid usage [ Time Frame: Length of Stay In PACU (Approximately 5-7 hours after intervention) ] [ Designated as safety issue: No ]
    The investigators will examine the difference in the total opioid usage. We will compare medications separately and in total equivalent units (using an opioid conversion table).
  • Degree of Doppler color agitation [ Time Frame: Immediately after intervention ] [ Designated as safety issue: No ]
    The investigators will examine the relationship between the degree of Doppler color agitation (evaluated at the time the catheter is placed) and block success (i.e., the outcome in the primary analysis). Degree of agitation color will be defined as the percentage of nerve covered during the color agitation.
Same as current
Not Provided
Not Provided
 
Comparison of Perineural Catheter Depth for the Continuous Popliteal Nerve Block Using Ultrasound Guidance and Dermabond
Comparison of Perineural Catheter Depth for the Continuous Popliteal Nerve Block Using Ultrasound Guidance and Dermabond

The study will investigate the difference in success rate between popliteal peripheral nerve catheters placed at 1 centimeter compared to 5 centimeters past the tip of a Tuohy needle.

Traditionally for the lower extremity, peripheral nerve catheters have been threaded greater than or equal to 5 centimeters past the tip of the Tuohy needle. The major rational for this practice is to reduce dislodgement. However, the greater the distance that a catheter is advanced, the greater the risk of contacting undesired structures, kinking, looping and knotting. For the continuous popliteal nerve block, the catheter is threaded perpendicular to the course of the nerve. This could result in the tip of the catheter being a significant distance from the targeted nerve which may lead to a decrease in the success rate or efficacy of the block.

Greater efficacy may be seen if the needle is closer to its target. This may be quantified by documenting a faster onset of motor and sensory changes and/or a lower catheter infusion rate required to maintain pain control. The study will investigate the difference in success rate between popliteal peripheral nerve catheters placed at 1 centimeter compared to 5 centimeters past the tip of a Tuohy needle.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Outcomes Assessor)
Primary Purpose: Treatment
Neuromuscular Inhibition
  • Procedure: 1 cm
    A Tuohy needle will be advanced in-plane with the bevel cephalad to a point that lies between the tibial and common peroneal branches of the sciatic nerve. The catheter will be advanced 1 cm past the tip of the Tuohy
    Other Names:
    • 18 gauge 100mm Contiplex Tuohy needle
    • 20-gauge non-stimulating catheter
  • Procedure: 5 cm
    A Tuohy needle will be advanced in-plane with the bevel cephalad to a point that lies between the tibial and common peroneal branches of the sciatic nerve. The catheter will be advanced 5 cm past the tip of the Tuohy
    Other Names:
    • 18 gauge 100mm Contiplex Tuohy needle
    • 20-gauge non-stimulating catheter
  • Experimental: Group 1
    Intervention: Procedure: 1 cm
  • Experimental: Group 2
    Intervention: Procedure: 5 cm
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
80
June 2013
May 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Will be having a popliteal nerve blocks
  • Do not meet any of the exclusion criteria listed below.

Exclusion Criteria:

  • < 18 years old
  • BMI > 35
  • Pregnant patients
  • Diabetes mellitus or patients with known neuropathy
  • Amputations & polytrauma patients
  • Patients allergic to local anesthetics
  • Chronic Pain patients
  • Patients in whom communication is a problem
Both
18 Years and older
No
Contact: Jennifer Morse, MS, CCRP 615-936-8495 jennifer.morse@vanderbilt.edu
United States
 
NCT01591603
120382
Yes
Clifford Bowens, Vanderbilt University
Vanderbilt University
Not Provided
Principal Investigator: Clifford Bowens, M.D. Vanderbilt University
Vanderbilt University
December 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP